Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06011499 · ClinicalTrials.gov registry record · NA
Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE
A NA study of Prostate Carcinoma, sponsored by OHSU Knight Cancer Institute.
- Recruiting
- Registry status
- NA
- Development phase
- 250
- Enrollment target
- 2
- Study locations
NCT06011499 is a NA study of Prostate Carcinoma that is actively recruiting participants, run by OHSU Knight Cancer Institute. The registered enrollment target is 250 participants, below the 1,498-participant average among 59 other Prostate Carcinoma trials with a reported enrollment target (83% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT06011499, a NA study of Prostate Carcinoma, is actively recruiting participants, sponsored by OHSU Knight Cancer Institute.
- RECRUITING
- Registry status
- NA
- Development phase
- 250 participants
- Enrollment target
- 2
- Study locations
Study Summary
This clinical trial tests the effectiveness of an online weight loss plus resistance training intervention (iLIVE) to decrease obesity and improve frailty in men with prostate cancer who received androgen deprivation therapy (ADT). Androgen deprivation therapy increases the risk of frailty, weight gain and obesity in prostate cancer survivors. The combination of frailty and obesity can lead to a decrease in quality of life and an increased risk of recurrent falls. Using iLIVE may improve obesity and frailty in men with prostate cancer who receive ADT.
Conditions Studied
Interventions
- OTHER Internet-Based Exercise Intervention
- OTHER Internet-Based Diet Intervention
- OTHER Education Intervention
Study Locations (2)
Alabama
- University of Alabama - Birmingham
Oregon
- OHSU Knight Cancer Institute - Portland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 250 participants |
| Start Date | 2024-03-12 |
| Est. Completion | 2027-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06011499
The ClinicalTrials.gov registry entry for NCT06011499 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,498-participant average among 59 other Prostate Carcinoma trials with a reported enrollment target (83% lower). The listed sponsor is OHSU Knight Cancer Institute, which has 211 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Prostate Carcinoma appearing as the primary indexed condition, and to 3 interventions - of which Internet-Based Exercise Intervention is the first listed.
NCT06011499 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Alabama, Oregon.
Frequently Asked Questions
What is clinical trial NCT06011499 about?
NCT06011499 is a clinical study titled "Internet-Based Lifestyle Intervention to Eradicate Obese Frailty in Prostate Cancer Survivors, iLIVE". This clinical trial tests the effectiveness of an online weight loss plus resistance training intervention (iLIVE) to decrease obesity and improve frailty in men with prostate cancer who received androgen deprivation therapy (ADT). Androgen deprivation therapy increases the risk of frailty, weight g...
What is the current status of trial NCT06011499?
This trial is currently recruiting. It is a NA study. The enrollment target is 250 participants. The study started on 2024-03-12. Estimated completion is 2027-12-31.
What conditions does trial NCT06011499 study?
This clinical trial studies the following conditions: Prostate Carcinoma.
What interventions are being tested in trial NCT06011499?
The interventions under investigation include: Internet-Based Exercise Intervention (OTHER), Internet-Based Diet Intervention (OTHER), Education Intervention (OTHER).
Who is sponsoring clinical trial NCT06011499?
This trial is sponsored by OHSU Knight Cancer Institute, which has 211 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06011499 being conducted?
This trial has 2 study locations across Alabama, Oregon. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Prostate Carcinoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate Cancer
RECRUITING · NA
-
Light Therapy and Occupational Therapy Fatigue Management-Based Intervention for Patients With Genitourinary Cancers
RECRUITING · NA
-
[18F]-rhPSMA PET-CT Imaging Performance in Patients With Prostate Cancer
RECRUITING · NA
-
Brain and Pelvic Floor Muscle Activity of Patients Who Had or Are Undergoing Robot-Assisted Radical Prostatectomy
RECRUITING · NA
-
Reduction of Gastrointestinal Toxicity in Prostate Cancer by Proton Spot Placement
RECRUITING · NA
-
MRI-Based Machine Learning Approach Versus Radiologist MRI Reading for the Detection of Prostate Cancer, The PRIMER Trial
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.